Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 4 of 4 for “"Pathogen reduction technology"”.

  1. Investigation of 405-nm light as a pathogen reduction technology for human blood plasma : evaluation of antimicrobial action & protein compatibility

    … entering the blood supply remains. Pathogen reduction technologies (PRTs)have been developed to improve blood product safety by proactively treating toremove infectious agents. Whilst these existing PRTs provide broad-spectrumantimicrobial activity, treatments fall short in …

    strathclyde Repository record for Investigation of 405-nm light as a pathogen reduction technology for human blood plasma : evaluation of antimicrobial action & protein compatibility (opens in a new tab)

  2. In vitro μελέτη της αιμοστατικής λειτουργίας των επεξεργασμένων με ριβοφλαβίνη αιμοπεταλίων αφαίρεσης

    Reducing the risk of pathogen transmission to transfusion recipients is one of the great concerns in transfusion medicine. Important among the measures suggested to minimise pathogen transmission is pathogen reduction technology (PRT) systems. The Mirasol PRT System for platelets and plasma uses …

    greece Repository record for In vitro μελέτη της αιμοστατικής λειτουργίας των επεξεργασμένων με ριβοφλαβίνη αιμοπεταλίων αφαίρεσης (opens in a new tab)

  3. Σύγκριση της αιμοστατικής λειτουργίας των επεξεργασμένων με ριβοφλαβίνη αιμοπεταλίων αφαίρεσης, σε ασκούς με PAS

    Background - The impact of pathogen reduction technology (PRT) such as Mirasol, and the effect of platelet additive solutions (PAS) on the activity and hemostatic profile of transfused apheresis platelets remain largely unknown. The aim of this study was to assess the in vitro hemostatic and …

    greece Repository record for Σύγκριση της αιμοστατικής λειτουργίας των επεξεργασμένων με ριβοφλαβίνη αιμοπεταλίων αφαίρεσης, σε ασκούς με PAS (opens in a new tab)

  4. Development of a scalable, high throughput, low energy consuming, rapid vaccine production device

    … study during pre-clinical testing. An existing pathogen reduction technology (PRT) called Mirasol PRT was capable of manufacturing small batches of vaccine material in the laboratory. The Mirasol PRT was developed for inactivating pathogen in blood products. The technology's batch processing …

    colostate Repository record for Development of a scalable, high throughput, low energy consuming, rapid vaccine production device (opens in a new tab)